Genes, dopamine and cortical signal-to-noise ratio in schizophrenia

Trends in Neurosciences

Volumn 27, Issue 11, 2004, Pages 683-690

  Winterer, Georg ^a,b   Weinberger, Daniel R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE;

BRAIN NERVE CELL; HUMAN; NERVE CELL EXCITABILITY; NERVE CELL NETWORK; PRIORITY JOURNAL; PYRAMIDAL TRACT; REVIEW; SCHIZOPHRENIA; SIGNAL NOISE RATIO; SIGNAL TRANSDUCTION; SYNAPSE;

CEREBRAL CORTEX; DOPAMINE; HUMANS; NERVE NET; SCHIZOPHRENIA;

EID: 5044225291     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2004.08.002     Document Type: Review

References (73)

1. D.R. Weinberger Prefrontal neurons and the genetics of schizophrenia Biol. Psychiatry 50 2001 825 844
2. G. Winterer Functional and effective frontotemporal connectivity and genetic risk for schizophrenia Biol. Psychiatry 54 2003 1181 1192
3. Harrison, P.G. and Weinberger, D.R. (2004) Schizophrenia genes and schizophrenic brain: on the matter of convergence. Mol. Psychiatry doi:10.1038/sj.mp.4001558
4. R.B. Zipursky Cerebral gray matter volume deficits in first episode psychosis Arch. Gen. Psychiatry 55 1998 540 546
5. C. Pantelis Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison Lancet 361 2003 281 288
6. W.G. Staal Structural brain abnormalities in patients with schizophrenia and their healthy siblings Am. J. Psychiatry 157 2000 416 421
7. L.D. Selemon Regional specificity in the neuropathologic substrates of schizophrenia: a morphometric analysis of Broca's area 44 and area 9 Arch. Gen. Psychiatry 60 2003 69 77
8. L.A. Glantz, and D.A. Lewis Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity Arch. Gen. Psychiatry 54 1997 943 952
9. M.D. Browning Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics Biol. Psychiatry 34 1993 529 535
10. C.E. Young SNAP-25 deficit in hippocampal connectivity in schizophrenia Cereb. Cortex 8 1998 261 268
11. S.L. Eastwood, and P.J. Harrison Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins Brain Res. Bull. 55 2001 569 578
12. L.A. Glantz, and D.A. Lewis Decreased dendritic spine density of prefrontal cortical pyramidal neurons in schizophrenia Arch. Gen. Psychiatry 57 2000 65 73
13. F. Impagnatiello A decrease of reelin expression as a putative vulnerability factor in schizophrenia Proc. Natl. Acad. Sci. U. S. A. 95 1998 15718 15723
14. H. Stefansson Neuregulin 1 and susceptibility to schizophrenia Am. J. Hum. Genet. 71 2002 877 892
15. R.E. Straub Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia Am. J. Hum. Genet. 71 2002 337 348
16. R. Hashimoto Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia Mol. Psychiatry 9 2004 299 307
17. C. Weickert Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex Arch. Gen. Psychiatry 61 2004 544 555
18. K. Mirnics Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia Mol. Psychiatry 6 2001 293 301
19. T. Dierks Activation of Heschl's gyrus during auditory hallucinations Neuron 22 1999 615 621
20. S.S. Shergill Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging Arch. Gen. Psychiatry 57 2000 1033 1038
21. S. Heckers Functional imaging of memory retrieval in deficit vs. nondeficit schizophrenia Arch. Gen. Psychiatry 56 1999 1117 1123
22. M.F. Egan Relative risk for cognitive impairments in siblings of patients with schizophrenia Biol. Psychiatry 50 2001 98 107
23. D.H. Ingvar, and G. Franzen Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia Acta Psychiatr. Scand. 50 1974 425 462
24. D.F. Salisbury Electrophysiology of schizophrenia S.R. Hirsch D.R. Weinberger Schizophrenia II 2003 Blackwell 298 309
25. D.S. Manoach Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured with fMRI Biol. Psychiatry 45 1999 1128 1137
26. J.H. Callicott Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited Cereb. Cortex 10 2000 1078 1092
27. J.H. Callicott Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down Am. J. Psychiatry 160 2003 2209 2215
28. P.S. Goldman-Rakic Cellular basis of working memory Neuron 14 1995 477 485
29. C. Constantinidis A role for inhibition in shaping the temporal flow of information in prefrontal cortex Nat. Neurosci. 5 2002 175 180
30. D. Durstewitz Neurocomputational models of working memory Nat. Neurosci. 3 Suppl. 1 2000 1184 1191
31. N. Brunel, and X.J. Wang Effects of neuromodulation in a cortical network model of object working memory dominated by recurrent inhibition J. Comput. Neurosci. 11 2001 63 85
32. G. Winterer Prefrontal broadband noise, working memory and genetic risk for schizophrenia Am. J. Psychiatry 161 2004 490 500
33. N.K. Logothetis Neurophysiological investigation of the basis of the MRI signal Nature 412 2001 150 157
34. M. Laruelle Dopamine transmission in the schizophrenic brain S.R. Hirsch D.R. Weinberger Schizophrenia II 2003 Blackwell 365 387
35. D.R. Weinberger Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism Arch. Gen. Psychiatry 45 1988 609 615
36. M. Akil Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects Am. J. Psychiatry 156 1999 1580 1589
37. A. Abi-Dargham Prefrontal dopamine D1 receptors and working memory in schizophrenia J. Neurosci. 22 2002 3708 3719
38. G. Guo Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophrenia Neuropsychopharmacology 28 2003 1703 1711
39. C.A. Ingham Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway J. Neurosci. 18 1998 4732 4743
40. R.H. Roth Stress and the mesocorticolimbic dopamine system Ann. N. Y. Acad. Sci. 537 1988 138 147
41. V.S. Mattay Dextroamphetamine enhances 'neural network-specific' physiological signals: a positron-emission tomography rCBF study J. Neurosci. 16 1996 4816 4822
42. 158-met genotype and individual variation in the brain response to amphetamine Proc. Natl. Acad. Sci. U. S. A. 100 2003 6186 6191
43. V.S. Mattay Dopaminergic modulation of cortical function in patients with Parkinson's disease Ann. Neurol. 51 2002 156 164
44. M.F. Egan Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia Proc. Natl. Acad. Sci. U. S. A. 98 2001 6917 6922
45. A. Diamond Genetic and neurochemical modulation of prefrontal cognitive functions in children Am. J. Psychiatry 161 2004 125 132
46. D. Durstewitz, and J.K. Seamans The computational role of dopamine D1 receptors in working memory Neural Netw. 15 2002 561 572
47. 1 receptors in prefrontal cortex Nature 376 1995 572 575
48. Y. Peters Prefrontal cortical up states are synchronized with ventral tegmental area activity Synapse 52 2004 143 152
49. J.K. Seamans Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons Proc. Natl. Acad. Sci. U. S. A. 98 2001 301 306
50. J. Wang, and P. O'Donnell D(1) dopamine receptors potentiate NMDA-mediated excitability increase in layer V prefrontal cortical pyramidal neurons Cereb. Cortex 11 2001 452 462
51. J.K. Seamans Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons J. Neurosci. 21 2001 3628 3638
52. H. Meltzer Multiple neurotransmitters involved in antipsychotic action S. Kapur Y. Lecrubier Dopamine in the Pathophysiology and Treatment of Schizophrenia 2003 Martin Dunitz London 177 205
53. P.D. Harvey, and R.S. Keefe Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment Am. J. Psychiatry 158 2001 176 184
54. 108/158 Met genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. Am. J. Psychiatry (in press)
55. D.G. Daniel The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia J. Neurosci. 11 1991 1907 1917
56. P. Anderer Perceptual and cognitive event-related potentials in neuropsychopharmacology: methodological aspects and clinical applications (pharmaco-ERP topography and tomography) Methods Find. Exp. Clin. Pharmacol. 24 Suppl C 2002 121 137
57. W.G. Frankle The synaptic hypothesis of schizophrenia Neuron 39 2003 205 216
58. 67 mRNA expression in a subset of prefrontal cortical GABA neurons in subjects with schizophrenia Arch. Gen. Psychiatry 57 2000 237 245
59. N. Gorelova Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex J. Neurophysiol. 88 2002 3150 3166
60. Z. Quin Dopaminergic and glutamatergic blocking drugs differentially regulate glutamic acid decarboxylase mRNA in mouse brain Brain Res. Mol. Brain Res. 21 1994 293 302
61. J. Bacci Effects of intralaminar thalamic nuclei lesion on glutamic acid decarboxylase (GAD65 and GAD67) and cytochrome oxidase subunit I mRNA expression in the basal ganglia of the rat Eur. J. Neurosci. 15 2002 1918 1928
62. L. Pei Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors J. Neurosci. 24 2004 1149 1158
63. B. Moghaddam Bringing order to the glutamate chaos in schizophrenia Neuron 40 2003 881 884
64. J.H. Callicott Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia Am. J. Psychiatry 160 2003 709 719
65. G. Winterer P300 and genetic risk for schizophrenia Arch. Gen. Psychiatry 60 2003 1158 1167
66. G. Winterer Schizophrenia: reduced signal-to-noise ratio and impaired phase-locking during information processing Clin. Neurophysiol. 111 2000 837 849
67. A. Carlsson A paradigm shift in brain research Science 294 2001 1021 1024
68. D.R. Weinberger Implications of normal brain development for the pathogenesis of schizophrenia Arch. Gen. Psychiatry 44 1987 660 669
69. A. Grace Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia J. Neural Transm. Gen. Sect. 91 1993 111 134
70. S.R. Sesack, and D.B. Carr Selective prefrontal cortex inputs to dopamine cells: implications for schizophrenia Physiol. Behav. 77 2002 513 517
71. A. Meyer-Lindenberg Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia Nat. Neurosci. 5 2002 267 271
72. A. Bertolino The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia Neuropsychopharmacology 22 2000 125 132
73. M. Akil Catechol-O-methyltransferase genotype and dopamine regulation in the human brain J. Neurosci. 23 2003 2008 2013